Oncotarget

Research Papers:

This article has been corrected. Correction in: Oncotarget. 2016; 7(41):67685.

From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity

Marc Aubry _, Marie de Tayrac, Amandine Etcheverry, Anne Clavreul, Stéphan Saikali, Philippe Menei and Jean Mosser

PDF  |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2015; 6:12094-12109. https://doi.org/10.18632/oncotarget.3297

Metrics: PDF 1331 views  |   HTML 1701 views  |   ?  


Abstract

Marc Aubry2,3,*, Marie de Tayrac1,2,4,*, Amandine Etcheverry1,2,4, Anne Clavreul6, Stéphan Saikali5,8, Philippe Menei6,7, Jean Mosser1,2,3,4

1CNRS, UMR 6290, Institut de Génétique et Développement de Rennes (IGdR), Rennes F-35043, France

2Université Rennes1, UEB, UMS 3480 Biosit, Faculté de Médecine, Rennes F-35043, France

3Plate-forme Génomique Santé Biosit, Université Rennes1, Rennes F-35043, France

4CHU Rennes, Service de Génétique Moléculaire et Génomique, Rennes F-35033, France

5CHU Rennes, Service d’Anatomie et Cytologie Pathologiques, Rennes F-35033, France

6INSERM UMR-1066, Micro et Nano-Médecines Biomimétiques (MINT), Angers F-49933, France

7CHU Angers, Département de Neurochirurgie, Angers F-49933, France

8Service d’Anatomie Pathologique, Hôpital de l’Enfant-Jésus, Québec, Canada

*These authors have contributed equally to this work

Correspondence to:

Marc Aubry, e-mail: marc.aubry@univ-rennes1.fr

Keywords: glioblastoma, intratumor heterogeneity, integrative functional genomics, invasion

Received: January 14, 2015     Accepted: April 06, 2015     Published: April 16, 2015

ABSTRACT

Glioblastoma (GB) is a highly invasive primary brain tumor that almost systematically recurs despite aggressive therapies. One of the most challenging problems in therapy of GB is its extremely complex and heterogeneous molecular biology. To explore this heterogeneity, we performed a genome-wide integrative screening of three molecular levels: genome, transcriptome, and methylome. We analyzed tumor biopsies obtained by neuro-navigation in four distinct areas for 10 GB patients (necrotic zone, tumor zone, interface, and peripheral brain zone). We classified samples and deciphered a key genes signature of intratumor heterogeneity by Principal Component Analysis and Weighted Gene Co-expression Network Analysis. At the genome level, we identified common GB copy number alterations and but a strong interindividual molecular heterogeneity. Transcriptome analysis highlighted a pronounced intratumor architecture reflecting the surgical sampling plan of the study and identified gene modules associated with hallmarks of cancer. We provide a signature of key cancer-heterogeneity genes highly associated with the intratumor spatial gradient and show that it is enriched in genes with correlation between methylation and expression levels. Our study confirms that GBs are molecularly highly diverse and that a single tumor can harbor different transcriptional GB subtypes depending on its spatial architecture.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3297